Next Science Ltd
ASX:NXS
Next Science Ltd
ASX:NXS
Price:
0.33 AUD
3.13%
Market Closed
Updated:
May 4, 2024
Section:
Relative Value
The Relative Value of one
NXS
stock under the Base Case scenario is
1.24
AUD.
Compared to the current market price of 0.33 AUD,
Next Science Ltd
is
Undervalued by 73%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NXS
Relative Value
Base Case
1.24
AUD
Undervaluation 73%
Valuation Multiples
Multiples Across Competitors
NXS Competitors Multiples
Next Science Ltd Competitors
Next Science Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Next Science Ltd
ASX:NXS
|
96.3m AUD | 2.9 | -3.9 | -3.5 | -3.5 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.4T JPY | 8.5 | 38.3 | 23.2 | 28.7 | |
| CH |
|
Alcon AG
SIX:ALC
|
35.6B CHF | 4.2 | 40.4 | 18 | 36.6 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
193.3B DKK | 7.7 | 39.7 | 26.1 | 30.3 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
21.7B USD | 5.5 | 46.9 | 25.8 | 31.3 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
18B USD | 4.9 | 61.9 | 22.7 | 38.5 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.3T KRW | 310 | -70.3 | -114.6 | -105.7 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
55.6B CNY | 14.1 | 33.6 | 29.2 | 29.2 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 3.1 | 51.1 | 46.8 | 50.9 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | 1.5 | -44.4 | 11.5 | 24.7 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.2B USD | 4 | 15.8 | 11.6 | 13.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
